First Time Loading...

Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 9.18 USD 0.88% Market Closed
Updated: Apr 27, 2024

Phathom Pharmaceuticals Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Phathom Pharmaceuticals Inc
Cash from Financing Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Cash from Financing Activities
$367.6m
CAGR 3-Years
48%
CAGR 5-Years
187%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Financing Activities
-$15.8B
CAGR 3-Years
-32%
CAGR 5-Years
3%
CAGR 10-Years
-7%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Financing Activities
-$9.4B
CAGR 3-Years
-101%
CAGR 5-Years
-22%
CAGR 10-Years
-24%
Pfizer Inc
NYSE:PFE
Cash from Financing Activities
$26.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Cash from Financing Activities
-$4.8B
CAGR 3-Years
-19%
CAGR 5-Years
18%
CAGR 10-Years
2%
Eli Lilly and Co
NYSE:LLY
Cash from Financing Activities
$3.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Phathom Pharmaceuticals Inc's Cash from Financing Activities?
Cash from Financing Activities
367.6m USD

Based on the financial report for Dec 31, 2023, Phathom Pharmaceuticals Inc's Cash from Financing Activities amounts to 367.6m USD.

What is Phathom Pharmaceuticals Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
187%

Over the last year, the Cash from Financing Activities growth was 206%. The average annual Cash from Financing Activities growth rates for Phathom Pharmaceuticals Inc have been 48% over the past three years , 187% over the past five years .